Literature DB >> 11327730

Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2).

M Ababneh1, C Götz, M Montenarh.   

Abstract

We previously found that p53 binds to the catalytic subunit of the p34(cdc2)/cyclin B1-kinase. In the present study we analyzed the functional consequences of this interaction. Binding of wild-type p53 to p34(cdc2)/cyclin B1 results in a significant decrease of its histone H1 kinase activity. Binding of p53 to the kinase is a prerequisite for the inhibition because a mutant p53 which lacks the binding region fails to influence the enzymatic activity. Furthermore, by using C-terminal fragments of p53 it became obvious that also some other structural elements in the N-terminal region are necessary for the inhibitory effect. Our present study provides evidence that p53 might regulate cell-cycle checkpoints not only on the transcriptional level but also by binding to the cell-cycle regulating kinase p34(cdc2).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327730     DOI: 10.1006/bbrc.2001.4792

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Multinucleation of koilocytes is in fact multilobation and is related to aberration of the G2 checkpoint.

Authors:  N H Cho; S Kang; S Hong; G B Jeong; I W Choi; H J Choi; H K Choi
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

2.  Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.

Authors:  V C Padmakumar; Eiman Aleem; Cyril Berthet; Mary Beth Hilton; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

3.  A comparative analysis of gene-expression data of multiple cancer types.

Authors:  Kun Xu; Juan Cui; Victor Olman; Qing Yang; David Puett; Ying Xu
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

4.  Compound C Inhibits B16-F1 Tumor Growth in a Syngeneic Mouse Model Via the Blockage of Cell Cycle Progression and Angiogenesis.

Authors:  Yun Taek Lee; So Hyun Lim; Boram Lee; Insug Kang; Eui-Ju Yeo
Journal:  Cancers (Basel)       Date:  2019-06-13       Impact factor: 6.639

5.  Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion.

Authors:  Myungyeon Lee; Na Yeon Ham; Chi Yeon Hwang; Jiwon Jang; Boram Lee; Joo-Won Jeong; Insug Kang; Eui-Ju Yeo
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.